Home » Topics » Regulatory

Regulatory
RSS

First stem cell-based medicinal product approved in Europe

Feb. 23, 2015

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Feb. 16, 2015

FDA approves lenvatinib for thyroid cancer

Feb. 16, 2015

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Feb. 9, 2015

FDA grants accelerated approval for Ibrance in advanced breast cancer

Feb. 4, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

FDA approves first drug for Waldenstrom's macroglobulinemia

Feb. 2, 2015

FDA approves Vyvanse for binge eating disorder

Feb. 2, 2015

FDA approves Bristol-Myers Squibb's Evotaz for HIV-1 infection

Jan. 30, 2015

FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD

Jan. 27, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.